Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis

Young Ki Lee, Young-Joo Kwon, Jong Woo Yoon, Kyung Sik Oh, Dae-Ryong Cha, Won Yong Cho, Kuhl Huh, Heui Jung Pyo, Hyoung Kyu Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hyperhomocyst(e)inemia is an established risk factor for atherosclerosis. We performed this study to identify the correlating variables and risk factors for atherosclerosis, as measured by the atherosclerotic score (AS), and to determine the relative risk for cardiovascular disease in relation to plasma homocyst(e)ine levels in patients on chronic hemodialysis. We evaluated and measured 61 patients on chronic hemodialysis for clinical and biochemical parameters including atherosclerotic score (AS) and plasma homocyst(e)ine. We divided patients into high and low groups, first, by the mean AS, and second, by the median value of plasma total homocyst(e)ine levels. Then we compared the variables between the two groups. Out of the 61 patients, the median plasma total homocyst(e)ine level was 24.4 μmol/L (mean±SD, 27.7±17.4; range, 9.8-127.4 μmol/L), and the median AS was 5 (mean±SD, 6.2±2.8; range, 3-13) out of a possible 20 points. AS was significantly correlated with plasma total homocyst(e)ine levels (r=0.37) and age (r=0.67). Through multivariate analysis, plasma total homocyst(e)ine level and age were determined as significant risk factors for the high-AS group (p<0.05). However, plasma total homocyst(e)ine level did not correlate with age (p>0.05). Eighteen of the 61 patients, presented with cardiovascular disease until the present study, had an AS>6. Cardiovascular disease was found more often in the high-homocyst(e)ine group (>24.4 μmol/L) than in the low-homocyst(e)ine group (odds ratio, 9.3; 95% confidence interval, 2.3-37.4). Regardless of age, hyperhomocyst(e)inemia (especially homocyst(e)ine levels >24.4 μmol/L) is a risk factor that can be modified for the development of cardiovascular disease in patients on chronic hemodialysis.

Original languageEnglish
Pages (from-to)193-198
Number of pages6
JournalJournal of Korean Medical Science
Volume14
Issue number2
Publication statusPublished - 1999 Apr 1

Fingerprint

Renal Dialysis
Atherosclerosis
Cardiovascular Diseases
Multivariate Analysis
Odds Ratio
Confidence Intervals

Keywords

  • Atherosclerosis
  • Dialysis
  • Homocysteine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis. / Lee, Young Ki; Kwon, Young-Joo; Yoon, Jong Woo; Oh, Kyung Sik; Cha, Dae-Ryong; Cho, Won Yong; Huh, Kuhl; Pyo, Heui Jung; Kim, Hyoung Kyu.

In: Journal of Korean Medical Science, Vol. 14, No. 2, 01.04.1999, p. 193-198.

Research output: Contribution to journalArticle

Lee, YK, Kwon, Y-J, Yoon, JW, Oh, KS, Cha, D-R, Cho, WY, Huh, K, Pyo, HJ & Kim, HK 1999, 'Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis', Journal of Korean Medical Science, vol. 14, no. 2, pp. 193-198.
Lee, Young Ki ; Kwon, Young-Joo ; Yoon, Jong Woo ; Oh, Kyung Sik ; Cha, Dae-Ryong ; Cho, Won Yong ; Huh, Kuhl ; Pyo, Heui Jung ; Kim, Hyoung Kyu. / Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis. In: Journal of Korean Medical Science. 1999 ; Vol. 14, No. 2. pp. 193-198.
@article{2852568b5fa547aea6a89786a05c60be,
title = "Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis",
abstract = "Hyperhomocyst(e)inemia is an established risk factor for atherosclerosis. We performed this study to identify the correlating variables and risk factors for atherosclerosis, as measured by the atherosclerotic score (AS), and to determine the relative risk for cardiovascular disease in relation to plasma homocyst(e)ine levels in patients on chronic hemodialysis. We evaluated and measured 61 patients on chronic hemodialysis for clinical and biochemical parameters including atherosclerotic score (AS) and plasma homocyst(e)ine. We divided patients into high and low groups, first, by the mean AS, and second, by the median value of plasma total homocyst(e)ine levels. Then we compared the variables between the two groups. Out of the 61 patients, the median plasma total homocyst(e)ine level was 24.4 μmol/L (mean±SD, 27.7±17.4; range, 9.8-127.4 μmol/L), and the median AS was 5 (mean±SD, 6.2±2.8; range, 3-13) out of a possible 20 points. AS was significantly correlated with plasma total homocyst(e)ine levels (r=0.37) and age (r=0.67). Through multivariate analysis, plasma total homocyst(e)ine level and age were determined as significant risk factors for the high-AS group (p<0.05). However, plasma total homocyst(e)ine level did not correlate with age (p>0.05). Eighteen of the 61 patients, presented with cardiovascular disease until the present study, had an AS>6. Cardiovascular disease was found more often in the high-homocyst(e)ine group (>24.4 μmol/L) than in the low-homocyst(e)ine group (odds ratio, 9.3; 95{\%} confidence interval, 2.3-37.4). Regardless of age, hyperhomocyst(e)inemia (especially homocyst(e)ine levels >24.4 μmol/L) is a risk factor that can be modified for the development of cardiovascular disease in patients on chronic hemodialysis.",
keywords = "Atherosclerosis, Dialysis, Homocysteine",
author = "Lee, {Young Ki} and Young-Joo Kwon and Yoon, {Jong Woo} and Oh, {Kyung Sik} and Dae-Ryong Cha and Cho, {Won Yong} and Kuhl Huh and Pyo, {Heui Jung} and Kim, {Hyoung Kyu}",
year = "1999",
month = "4",
day = "1",
language = "English",
volume = "14",
pages = "193--198",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "2",

}

TY - JOUR

T1 - Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis

AU - Lee, Young Ki

AU - Kwon, Young-Joo

AU - Yoon, Jong Woo

AU - Oh, Kyung Sik

AU - Cha, Dae-Ryong

AU - Cho, Won Yong

AU - Huh, Kuhl

AU - Pyo, Heui Jung

AU - Kim, Hyoung Kyu

PY - 1999/4/1

Y1 - 1999/4/1

N2 - Hyperhomocyst(e)inemia is an established risk factor for atherosclerosis. We performed this study to identify the correlating variables and risk factors for atherosclerosis, as measured by the atherosclerotic score (AS), and to determine the relative risk for cardiovascular disease in relation to plasma homocyst(e)ine levels in patients on chronic hemodialysis. We evaluated and measured 61 patients on chronic hemodialysis for clinical and biochemical parameters including atherosclerotic score (AS) and plasma homocyst(e)ine. We divided patients into high and low groups, first, by the mean AS, and second, by the median value of plasma total homocyst(e)ine levels. Then we compared the variables between the two groups. Out of the 61 patients, the median plasma total homocyst(e)ine level was 24.4 μmol/L (mean±SD, 27.7±17.4; range, 9.8-127.4 μmol/L), and the median AS was 5 (mean±SD, 6.2±2.8; range, 3-13) out of a possible 20 points. AS was significantly correlated with plasma total homocyst(e)ine levels (r=0.37) and age (r=0.67). Through multivariate analysis, plasma total homocyst(e)ine level and age were determined as significant risk factors for the high-AS group (p<0.05). However, plasma total homocyst(e)ine level did not correlate with age (p>0.05). Eighteen of the 61 patients, presented with cardiovascular disease until the present study, had an AS>6. Cardiovascular disease was found more often in the high-homocyst(e)ine group (>24.4 μmol/L) than in the low-homocyst(e)ine group (odds ratio, 9.3; 95% confidence interval, 2.3-37.4). Regardless of age, hyperhomocyst(e)inemia (especially homocyst(e)ine levels >24.4 μmol/L) is a risk factor that can be modified for the development of cardiovascular disease in patients on chronic hemodialysis.

AB - Hyperhomocyst(e)inemia is an established risk factor for atherosclerosis. We performed this study to identify the correlating variables and risk factors for atherosclerosis, as measured by the atherosclerotic score (AS), and to determine the relative risk for cardiovascular disease in relation to plasma homocyst(e)ine levels in patients on chronic hemodialysis. We evaluated and measured 61 patients on chronic hemodialysis for clinical and biochemical parameters including atherosclerotic score (AS) and plasma homocyst(e)ine. We divided patients into high and low groups, first, by the mean AS, and second, by the median value of plasma total homocyst(e)ine levels. Then we compared the variables between the two groups. Out of the 61 patients, the median plasma total homocyst(e)ine level was 24.4 μmol/L (mean±SD, 27.7±17.4; range, 9.8-127.4 μmol/L), and the median AS was 5 (mean±SD, 6.2±2.8; range, 3-13) out of a possible 20 points. AS was significantly correlated with plasma total homocyst(e)ine levels (r=0.37) and age (r=0.67). Through multivariate analysis, plasma total homocyst(e)ine level and age were determined as significant risk factors for the high-AS group (p<0.05). However, plasma total homocyst(e)ine level did not correlate with age (p>0.05). Eighteen of the 61 patients, presented with cardiovascular disease until the present study, had an AS>6. Cardiovascular disease was found more often in the high-homocyst(e)ine group (>24.4 μmol/L) than in the low-homocyst(e)ine group (odds ratio, 9.3; 95% confidence interval, 2.3-37.4). Regardless of age, hyperhomocyst(e)inemia (especially homocyst(e)ine levels >24.4 μmol/L) is a risk factor that can be modified for the development of cardiovascular disease in patients on chronic hemodialysis.

KW - Atherosclerosis

KW - Dialysis

KW - Homocysteine

UR - http://www.scopus.com/inward/record.url?scp=0033109706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033109706&partnerID=8YFLogxK

M3 - Article

C2 - 10331567

AN - SCOPUS:0033109706

VL - 14

SP - 193

EP - 198

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 2

ER -